Consensus and supplementsManagement of Hyperkeratosis of the Lower Limb

Management of Hyperkeratosis of the Lower Limb

Supplements

Management of  Hyperkeratosis of the Lower LimbThe purpose of this Best Practice Guidance is to present guidance on the prevention and management of hyperkeratosis of the lower limb.

At present there are no national guidelines for the management of hyperkeratosis. Hyperkeratosis is an increased thickening of the stratum corneum resulting in thickened, scaly skin (International Lymphoedema Framework [ILF], 2012; European Wound Management Association [EWMA], 2005). Hyperkeratosis can become severe, which can make treatment and adjunctive therapies (e.g. compression) more difficult. However, the condition can be managed effectively given appropriate and timely assessment and treatment. Supported by Activa